Government missed deadline after deadline in Covid-19 vaccine rollout

The rollout of Covid-19 vaccines in South Africa has been plagued by inefficiency, misfortune, and a series of unrealistic aims, resulting in deadlines being repeatedly missed.

South Africa’s initial target was to vaccinate 1.2 million people by the end of March, and 40 million people by the end of 2021.

According to the government update on 1 July, 3,026,636 people have received a vaccine.

While there has been a substantial improvement in the number of South Africans being vaccinated since March, if things progress as they are now, it is likely that government will miss its goal to vaccinate 67% of South Africa’s population by year-end.

According to the Media Hack Collective vaccine calculator, South Africa has administered an average of 22,757 vaccines per day since 17 February.

This number has steadily increased but the calculator shows that, assuming the two-shot Pfizer vaccine is going to be used to inoculate most of South Africa, the number of vaccines administered per day on average has to be over 422,000 assuming a two-shot vaccination — and this number is only increasing with each passing day.

In his address to the nation this past Sunday, President Cyril Ramaphosa acknowledged that South Africa has a shortage of vaccines and added that we are not the only country in the world waiting for its vaccines to arrive.

“I get calls every day from leaders on the continent about the availability of vaccines, [also] from as far afield as the Caribbean,” Ramaphosa said.

“The entire world is crying out for vaccines and we are doing everything we can to make sure the vaccines are here.”

tito mboweni minister of finance South Africa
Tito Mboweni, Minister of Finance

On 24 November 2020, Finance Minister Tito Mboweni confirmed in a Bloomberg webinar that government would invest in the Covax vaccine initiative for R500 million rand. The goal was to see South Africa at “the front of the queue” for the acquisition of vaccines.

This announcement was made after the government had already missed the initial October 9 payment deadline to join Covax.

President Ramaphosa stated that this initial investment was aimed at securing enough vaccinations from Covax to cover “at least 10% of the population” (around 6 million) within the first half of 2021.

Another payment, this time of R327 million was due for payment to Covax on December 15. This deadline was also missed. The Solidarity Fund, which was responsible for the payment, reportedly did not receive the green light from government to initiate the transaction due to an administrative lapse.

Cyril Ramaphosa South African President
President Cyril Ramaphosa

Before January there had been no sign of government attempts to procure vaccines or vaccine production besides the Covax initiative.

On 7 January, Health Minister Zweli Mkhize presented the official plan for the South African vaccine rollout strategy

It stipulated a three-stage programme that the government believed would see 67-70% of the population vaccinated by the end of 2021.

This was followed by an announcement that the government had secured 1.5 million AstraZeneca vaccinations and that these would be delivered by February, enabling 750,000 health workers to be vaccinated by the end of February.

astrazeneca covid 19 vaccine

Shortly thereafter, on 12 January, President Ramaphosa announced that the government had secured 20 million vaccines. He stated that these would be delivered “mainly” in the first half of the year, though deals were yet to be finalised.

The confirmation of bilateral agreements relieved earlier frustrations relating to South Africa’s total dependence on Covax, which had by February not provided a single vaccine.

The goalposts for Covax were moved from providing vaccinations for 10% of the population within the first half of the year, to 10% by the end of the year.

On 22 January, a further 9 million vaccines were said to be secured in an agreement with Johnson & Johnson and, by the end of the month, Mkhize announced that another 20 million were secured through an agreement with Pfizer.

These reported agreements saw the government move beyond its goal of securing 40 million vaccines, albeit on paper.

Zweli Mkhize South African Minister of Health
Zweli Mkhize

The AstraZeneca vaccines were set to arrive on 1 February, and Zweli Mkhize stated that distribution would begin between 10 to 14 days later.

Then came the reports that AstraZeneca — the only vaccine in South Africa at the time — only had a 22% efficacy against mild and moderate cases of the 501.V2 variant that had emerged in the second wave of infections.

The vaccine rollout was halted on 8 February, before it had even begun, though Mkhize said that doses from Johnson & Johnson and Pfizer would start arriving within four weeks.

Mkhize announced a substitute for South Africa’s first phase of vaccine rollouts on 16 February dubbed the “Sisonke study”.

According to the Minister, the rollout would begin that same week with the arrival of 80,000 Johnson & Johnson doses and another 500,000 doses could be expected within the subsequent four weeks.

He also said that 20 million doses of the Pfizer vaccine were expected to arrive by the end of March.

The circumstances surrounding the AstraZeneca vaccine did not cause a significant delay in the rollout, as the Sisonke study commenced on 17 February — 2 days after the AstraZeneca rollout would have begun.


By 11 March, 128,887 healthcare workers had been vaccinated, and Mkhize announced that the initial target of vaccinating 1.2 million healthcare workers by the end of March was unattainable due to vaccine shortages.

The government stated that it anticipated 500,000 doses of Johnson & Johnson and 600,000 doses from Pfizer by 31 March, falling far short of the 20 million doses of Pfizer that, in February, Mkhize said could be expected by the same date.

The Minister of Health maintained that the initial target of vaccinating 40 million South Africans had not been adjusted.

Mkhize’s assertion on 16 February that 500,000 doses of the Johnson & Johnson vaccine could be expected within four weeks was not achieved, with around 160,000 received at the time.

On 24 March, Medical Research Council president Professor Glenda Gray stated that the Sisonke trial aimed at 500,000 vaccinations by the end of April, as opposed to the initial phase one target of 1.2 million by end March.

prof glenda gray
Professor Glenda Gray, President of the South African Medical Research Council

President Ramaphosa announced on 25 March that the second phase of South Africa’s vaccine rollouts would begin in May.

On the same day of the president’s announcement, Acting Minister in the Presidency Khumbudzo Ntshavheni stated that the target for the end of April was still 1.2 million and that the rollout was on its way to reaching it, contradicting Gray’s statement from the previous day.

With just over 200,000 healthcare workers being vaccinated at the time of Ntshavheni’s announcement, this implied that around a million vaccines would have to be administered to healthcare workers in 36 days.

To achieve this would require 27,778 vaccinations a day, as opposed to the 5,700 daily doses the country was administering at the time.

President Ramaphosa said in a media briefing on March 29 that the end goal of 40 million vaccinated South Africans by the end of the year remained set.

Johnson and Johnson vaccine

Misfortune struck again on 16 April as South Africa’s vaccine rollout was halted due to concerns over blood clotting caused by the Johnson & Johnson vaccine.

Despite the delay caused by the Johnson & Johnson vaccine, the goal of vaccinating 1.2 million healthcare workers by 16 May was affirmed by the government, and vaccinations once again resumed on April 28.

The aim was to start the second phase of South Africa’s vaccine rollout on 17 May, allowing those over the age of 60 to get their shots.

The first batch of 325,000 Pfizer vaccine doses was received on 3 May and the target of 1.2 million vaccinations by 16 May was readjusted to 500,000 vaccinations. This new goal was also missed.

Phase two of the vaccine rollout commenced on 17 May as per the government’s schedule.

Mkhize stated that 4 million Pfizer doses were expected by June, as well as 2.2 million Johnson & Johnson doses.

cyril ramaphosa vaccination

Government aims to have 16.6 million South Africans vaccinated by 3 October, which is 94 days from now.

President Ramaphosa stated in his address this past Sunday that the vaccines are now starting to arrive at an adequate rate, admitting that there has been a shortage until now. He also said that he aims to have the daily vaccinations reach 300,000.

This is in line with the 288,000 daily vaccinations required to reach the 16.6 million goal by 3 October, assuming the goal is to fully vaccinate people using the two-shot Pfizer vaccine.

Yesterday, 30 June, over 120,000 people received their vaccinations, which is a positive indicator of the rollout expansion.

At the moment the education sector is at the centre of the program, with 238,315 staff being vaccinated so far, with the goal being set at 582,000 vaccinations by 8 July 2021

Vaccinations for people over 50 are set to begin on 15 July, with over 50% of people over 60 already vaccinated.

Registrations for people aged 50 and over are now open on the EVDS portal.

The table below summarises South Africa’s vaccine deadlines since October last year and shows how many were met.

Vaccine rollout deadlines
Month(s) Deadline set Deadline met
October to December 2020 10% of population vaccinated from Covax by mid-year No — 3,026,636 vaccinated by 30 June
Covax payment by 15 December No — Administrative lapse
January 67% of population (41 million) vaccinated by end 2021 Will need over 422,000 shots per day to reach
1 million AstraZeneca received by Feb Yes
750,000 health workers vaccinated by 28 Feb No — 70,527 vaccinated by 1 March
February AstraZeneca rollout by 15 Feb No — Doubt over vaccine efficacy against 501.V2 variant
Phase 2 to begin in March No — Began 17 May
J&J and Pfizer to arrive by 8 March Yes — 80,000 J&J on 16 Feb
500,000 J&J by 16 March No — 160,000 received by 16 March
20 million Pfizer by 31 March No — First 325,000 Pfizer received on 3 May
Rollout to begin on 17 February Yes
March 500,000 J&J by 31 March No — still 200,000 doses short on 9 April
600,000 Pfizer by 31 March No — First 325,000 Pfizer received on 3 May
500,000 vaccinations by 30 April No — 318,670 by 3 May
1.2 million vaccinations by 30 April No — 318,670 by 3 May
May 1.2 million vaccinated by 16 May No — 479,768 by 19 May
500,000 vaccinated by 16 May No — 479,768 by 19 May
Phase two to begin on 17 May Yes
June 16.6 million by 3 October Will need over 288,000 shots per day to reach
2.2 million J&J by end-June No — last received was 1.2 million between 24 – 27 June
4 million Pfizer by end-June  No — last received was 1.4 million between 24 – 27 June
July 582,000 educators and staff by 8 July Possible if 120,000 daily vaccinations maintained
Age 40+ vaccine registrations to start on 1 July No — changed to over age 50+
Age 50+ vaccine registrations to start on 1 July Yes
Age 50+ vaccinations to start on 15 July  TBD
Missed Met TBD
16 5 4

Now read: Deadlier coronavirus variant ravaging Gauteng

Latest news

Partner Content

Show comments


Share this article
Government missed deadline after deadline in Covid-19 vaccine rollout